For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of Xylem Inc (NYSE: XYL) closed at $151.53 in the last session, down -0.93% from day before closing price of $152.95. In other words, the price has decreased by -$0.93 from its previous closing price. On the day, 1.51 million shares were traded. XYL stock price reached its highest trading level at $154.2351 during the session, while it also had its lowest trading level at $151.42.
Ratios:
We take a closer look at XYL’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 30.98 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 39.88. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.96. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Barclays on September 19, 2025, initiated with a Overweight rating and assigned the stock a target price of $165.
On May 30, 2025, JP Morgan started tracking the stock assigning a Overweight rating and target price of $148.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 30 ’25 when CLAUDIA S. TOUSSAINT REVOCABLE bought 10,421 shares for $152.63 per share.
McShane Geri-Michelle sold 1,000 shares of XYL for $139,962 on Sep 05 ’25. The VP, CAO now owns 2,957 shares after completing the transaction at $139.96 per share. On Sep 05 ’25, another insider, GERI-MICHELLE MCSHANE, who serves as the Officer of the company, bought 1,000 shares for $139.96 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XYL now has a Market Capitalization of 36892864512 and an Enterprise Value of 38028865536. As of this moment, Xylem’s Price-to-Earnings (P/E) ratio for their current fiscal year is 38.98, and their Forward P/E ratio for the next fiscal year is 27.32. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.01. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.15 while its Price-to-Book (P/B) ratio in mrq is 3.29. Its current Enterprise Value per Revenue stands at 4.276 whereas that against EBITDA is 20.512.
Stock Price History:
The Beta on a monthly basis for XYL is 1.15, which has changed by 0.268458 over the last 52 weeks, in comparison to a change of 0.19088471 over the same period for the S&P500. Over the past 52 weeks, XYL has reached a high of $153.90, while it has fallen to a 52-week low of $100.47. The 50-Day Moving Average of the stock is 4.83%, while the 200-Day Moving Average is calculated to be 15.91%.
Shares Statistics:
According to the various share statistics, XYL traded on average about 1.23M shares per day over the past 3-months and 1238700 shares per day over the past 10 days. A total of 243.50M shares are outstanding, with a floating share count of 242.81M. Insiders hold about 0.27% of the company’s shares, while institutions hold 93.78% stake in the company. Shares short for XYL as of 1760486400 were 2679414 with a Short Ratio of 2.19, compared to 1757894400 on 2914971. Therefore, it implies a Short% of Shares Outstanding of 2679414 and a Short% of Float of 1.4099999.
Dividends & Splits
The forward annual dividend rate for XYL is 1.56, which was 1.56 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.010199412. The stock’s 5-year Average Dividend Yield is 1.13.
Earnings Estimates
The stock of Xylem Inc (XYL) is currently drawing attention from 16.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is $1.16, with high estimates of $1.23 and low estimates of $1.05.
Analysts are recommending an EPS of between $5.1 and $4.85 for the fiscal current year, implying an average EPS of $5.03. EPS for the following year is $5.53, with 20.0 analysts recommending between $5.72 and $5.27.
Revenue Estimates
According to 19 analysts,. The current quarter’s revenue is expected to be $2.37B. It ranges from a high estimate of $2.43B to a low estimate of $2.32B. As of. The current estimate, Xylem Inc’s year-ago sales were $2.26BFor the next quarter, 19 analysts are estimating revenue of $2.19B. There is a high estimate of $2.23B for the next quarter, whereas the lowest estimate is $2.15B.
A total of 17 analysts have provided revenue estimates for XYL’s current fiscal year. The highest revenue estimate was $9.4B, while the lowest revenue estimate was $8.96B, resulting in an average revenue estimate of $9.03B. In the same quarter a year ago, actual revenue was $8.56BBased on 20 analysts’ estimates, the company’s revenue will be $9.38B in the next fiscal year. The high estimate is $9.5B and the low estimate is $9.17B.
